# Peter E. Carson

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/peter-e-carson/

## Facts

| Field | Value |
| --- | --- |
| Citations | 37,740 |
| Field | Heart Failure Treatment and Management |
| h-index | 68 |
| i10-index | 127 |
| OpenAlex ID | https://openalex.org/A5039697719 |
| Works | 198 |

## Researcher papers

Showing 12 of 16.

- [Cardiac-Resynchronization Therapy with or without an Implantable Defibrillator in Advanced Chronic Heart Failure](https://scholariq.org/papers/cardiac-resynchronization-therapy-with-or-without-an-implantable-defibrillator/)
- [Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure](https://scholariq.org/papers/cardiovascular-and-renal-outcomes-with-empagliflozin-in-heart-failure/)
- [Empagliflozin in Heart Failure with a Preserved Ejection Fraction](https://scholariq.org/papers/empagliflozin-in-heart-failure-with-a-preserved-ejection-fraction/)
- [A Comparison of Enalapril with Hydralazine–Isosorbide Dinitrate in the Treatment of Chronic Congestive Heart Failure](https://scholariq.org/papers/a-comparison-of-enalapril-with-hydralazine-isosorbide-dinitrate-in-the-treatment/)
- [Irbesartan in Patients with Heart Failure and Preserved Ejection Fraction](https://scholariq.org/papers/irbesartan-in-patients-with-heart-failure-and-preserved-ejection-fraction/)
- [Combination of Isosorbide Dinitrate and Hydralazine in Blacks with Heart Failure](https://scholariq.org/papers/combination-of-isosorbide-dinitrate-and-hydralazine-in-blacks-with-heart-failure/)
- [Effect of Amlodipine on Morbidity and Mortality in Severe Chronic Heart Failure](https://scholariq.org/papers/effect-of-amlodipine-on-morbidity-and-mortality-in-severe-chronic-heart-failure/)
- [Racial differences in response to therapy for heart failure: Analysis of the vasodilator-heart failure trials](https://scholariq.org/papers/racial-differences-in-response-to-therapy-for-heart-failure-analysis-of-the/)
- [Prevalence and Significance of Alterations in Cardiac Structure and Function in Patients With Heart Failure and a Preserved Ejection Fraction](https://scholariq.org/papers/prevalence-and-significance-of-alterations-in-cardiac-structure-and-function-in/)
- [Effects of Vesnarinone on Morbidity and Mortality in Patients with Heart Failure](https://scholariq.org/papers/effects-of-vesnarinone-on-morbidity-and-mortality-in-patients-with-heart-failure/)
- [Effect of Empagliflozin on the Clinical Stability of Patients With Heart Failure and a Reduced Ejection Fraction](https://scholariq.org/papers/effect-of-empagliflozin-on-the-clinical-stability-of-patients-with-heart-failure/)
- [Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved Trial](https://scholariq.org/papers/effect-of-empagliflozin-on-worsening-heart-failure-events-in-patients-with-heart/)

## Researcher topics

- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)
- [Cardiac pacing and defibrillation studies](https://scholariq.org/topics/cardiac-pacing-and-defibrillation-studies/)
- [Cardiac electrophysiology and arrhythmias](https://scholariq.org/topics/cardiac-electrophysiology-and-arrhythmias/)
- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.